Trial Profile
Real-world clinical and economic outcomes in patients with type 2 diabetes initiating glargine disposable pen vs. insulin detemir disposable pen in a US managed care setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2015
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Sep 2011 New trial record
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.